Full history for every metric is available with a Kvantra account
Key financial summary
Financials in GBP| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | £m | 509 | 567 | 674 | 689 | 691 | 713 | 816 | 816 |
| Operating profit | £m | 134 | 134 | ||||||
| Net profit | £m | 0 | 111 | 120 | 116 | 97 | 84 | 119 | 119 |
| EPS reported | £ | 1.64 | 1.64 | ||||||
| Operating cashflow per share | £ | 1.67 | 1.67 | ||||||
| Capex per share | £ | 0.53 | 0.53 | ||||||
| FCF per share | £ | 1.14 | 1.14 | ||||||
| Free cash flow | £m | 83 | 83 | ||||||
| Net debt | £m | -285 | -277 | ||||||
| Book value equity | £m | 985 | 985 | ||||||
| Book value per share | £ | 13.53 | 13.53 | ||||||
| Number of shares | m | 72.76 | 72.76 | ||||||
| DPS (TTM paid) | £ | 1.35 | 0.78 |
Financial summary
Financials in GBP| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 31.22 | - | ||||||
| P/B LTM | x | 3.78 | 4.40 | ||||||
| P/S LTM | x | 4.57 | 5.31 | ||||||
| P/FCF LTM | x | 44.89 | 52.24 | ||||||
| EV/EBITDA LTM | x | 21.47 | 24.27 | ||||||
| EV/Sales LTM | x | 4.40 | 4.97 | ||||||
| Earnings Yield LTM | % | 3.20% | 2.74% | ||||||
| FCF Yield | % | 2.23% | 1.91% | ||||||
| Quality | |||||||||
| ROE | % | 12.08% | 12.53% | ||||||
| ROIC | % | 10.43% | 10.43% | ||||||
| Operating margin | % | 16.41% | 16.41% | ||||||
| Gross margin | % | 59.29% | 59.29% | ||||||
| FCF/Sales | % | 10.17% | 10.17% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | +42.61% | +42.61% | ||||||
| Sales Growth YoY | % | +14.41% | +14.41% | ||||||
| Net Income Growth YoY | % | +42.03% | +42.03% | ||||||
| FCF Growth | % | -18.35% | -18.35% | ||||||
| Operating Profit Growth | % | +24.10% | +24.10% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 1.53% | 1.31% | ||||||
| Dividend Growth | % | +704.76% | 0.00% | ||||||
| Payout Ratio | % | 47.64% | 47.78% | ||||||
| FCF/Debt | x | 6.14 | 6.14 | ||||||
| Net Debt/EBITDA | x | -0.80 | -0.80 | ||||||
| EBIT/Net interest | x | 33.79 | 33.79 | ||||||
| Net debt/market cap | % | -7.64% | -6.40% | ||||||
| Net debt/Equity | x | -0.29 | -0.28 | ||||||
| Gross debt/equity | x | 0.01 | 0.01 | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Renishaw plc is a British engineering and scientific technology enterprise, established in 1973, that operates globally. The company specializes in the conception, production, distribution, and maintenance of advanced metrology and healthcare innovations. Its diverse metrology offerings encompass coordinate measuring machine (CMM) solutions, machine tool probes and associated software, precision measurement systems, various gauging instruments, fixtures, styli, and a range of optical, magnetic, and interferometric laser encoders. Renishaw also provides additive manufacturing platforms, vacuum casting machines for plastics and metals, and mapping sensors. Within its healthcare division, products include dental scanning technology, neurosurgical robotics, planning software, drug delivery apparatus, advanced Raman microscopes, custom craniomaxillofacial implants, and analytical devices. Furthermore, the company extends its services to include asset financing and travel arrangements. Renishaw's clientele spans numerous critical sectors, such as aerospace, automotive, consumer electronics, medical, energy, heavy industry, and scientific research, alongside agriculture, construction, and precision manufacturing.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Based on consensus from external analysts. Not Kvantra's opinion.
Renishaw plc is a British engineering and scientific technology enterprise, established in 1973, that operates globally. The company specializes in the conception, production, distribution, and maintenance of advanced metrology and healthcare innovations. Its diverse metrology offerings encompass coordinate measuring machine (CMM) solutions, machine tool probes and associated software, precision measurement systems, various gauging instruments, fixtures, styli, and a range of optical, magnetic, and interferometric laser encoders. Renishaw also provides additive manufacturing platforms, vacuum casting machines for plastics and metals, and mapping sensors. Within its healthcare division, products include dental scanning technology, neurosurgical robotics, planning software, drug delivery apparatus, advanced Raman microscopes, custom craniomaxillofacial implants, and analytical devices. Furthermore, the company extends its services to include asset financing and travel arrangements. Renishaw's clientele spans numerous critical sectors, such as aerospace, automotive, consumer electronics, medical, energy, heavy industry, and scientific research, alongside agriculture, construction, and precision manufacturing.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free